Evidence map›Paper›PMID 34895285›Full record

Trial reportTrials2021

Treatment of urinary incontinence in women with chronic obstructive pulmonary disease-a randomised controlled study.

Stacey Haukeland-Parker, Bente Frisk, Martijn A Spruit, Signe Nilssen Stafne, Hege Hølmo Johannessen

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02614105 (UriCO - Effect of Pelvic Floor Muscle Training and Cough-suppression Therapy on Urinary Incontinence Amongst Women With Chronic Obstructive Pulmonary Disease; a Randomised Controlled Trial), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02614105 nacompletednot on this map

UriCO - Effect of Pelvic Floor Muscle Training and Cough-suppression Therapy on Urinary Incontinence Amongst Women With Chronic Obstructive Pulmonary Disease; a Randomised Controlled Trial

TypeinterventionalSponsorOstfold Hospital TrustRan2015 to 2018Enrolled35ConditionsChronic Obstructive Pulmonary Disease, Urinary IncontinenceArmsPelvic floor muscle training, Cough-suppression therapy, Control
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Stacey Haukeland-ParkerDepartment of Physical Medicine and Rehabilitation, Østfold Hospital Trust, Grålum, Norway. stacey.haukeland.parker@so-hf.no.ORCID http://orcid.org/0000-0003-1620-9848
Bente FriskDepartment of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway.
Martijn A SpruitDepartment of Research and Development, CIRO+, Horn, The Netherlands.
Signe Nilssen StafneDepartment of Public Health and Nursing, NTNU Faculty of Medicine and Health Sciences, Trondheim, Norway.
Hege Hølmo JohannessenDepartment of Physical Medicine and Rehabilitation, Østfold Hospital Trust, Grålum, Norway.
Fredrikstad Energi (Norway) · NOHaukeland University Hospital · NOMaastricht University · NLSt Olav's University Hospital · NOWestern Norway University of Applied Sciences · NO

Funding

Sykehuset Østfold AB3342
6 · The paper itself

Abstract

backgroundLittle is known regarding treatment of urinary incontinence (UI) in women with chronic obstructive pulmonary disease (COPD). The aim of the study was to explore the efficacy of pelvic floor muscle training (PFMT) or cough-suppression techniques (CST) on UI in women with COPD.

methodsA three-armed, two-centred, single-blinded, randomised controlled study was performed. Subjects were randomised to (a) PFMT for 16 weeks, (b) 2-3 educational sessions in CST, or (c) written information only. All participants completed questionnaires about UI, cough symptoms, and health status and underwent clinical examinations to evaluate the strength of the pelvic floor muscles and exercise capacity. Daily physical activity levels were measured using an activity monitor and lung function with spirometry. With a significance level of 5% and an 80% chance of detecting a significant difference between groups of 2.5 points on the ICIQ UI SF score, our sample size calculation showed that a total of 78 women, 26 in each group, was required to complete the study.

resultsDuring the period 2016 to 2018, 95 women were invited to the study. A total of 42 were recruited, three were excluded and 10 (24%) dropped out during the follow-up period. Mean ICIQ-UI SF total baseline score was 9.6 (range: 1-17) and 7.0 (range: 0-16) at follow-up. Changes in subjective UI as measured with the ICIQ-UI SF questionnaire were seen in the PFMT group and control group, but not in the CST group.

conclusionDue to the low number of available participants and recruitment difficulties including practical issues such as travel distance, lack of interest, poor state of health, and high number of comorbidities, our results are inconclusive. However, reduced subjective UI was observed in the PFMT and control groups with a trend towards best effect in the PFMT group. Screening for UI is advisable in all women with COPD to be able to identify and treat these women to reduce symptom burden and improve quality of life. Future studies should focus on barriers to recruitment as well as randomised controlled studies with larger sample sizes.

trial registrationClinicalTrials.gov NCT02614105. 25th November 2015.

Indexed as

Pulmonary Disease, Chronic ObstructiveUrinary IncontinenceExercise TherapyFemaleHumansPelvic FloorQuality of LifeTreatment OutcomeChronic obstructive pulmonary diseaseCough-suppression therapyPelvic floor muscle trainingUrinary incontinence

Identifiers

PMID34895285
PMCPMC8665568
OpenAlexW4200059277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.